Log In
Print
BCIQ
Print
Print this Print this
 

GM604

  Manage Alerts
Collapse Summary General Information
Company Genervon Biopharmaceuticals LLC
DescriptionEndogenous embryonic stage peptide that binds to a subunit of insulin receptor, insulin-like growth factor 1 (IGF1) receptor (IGF1R; CD221) and insulin-like growth factor-2 (IGF-2) receptor (IGF2R; M6PR)
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221) ; Insulin-like growth factor-2 (IGF-2) receptor (IGF2R) (M6PR)
Mechanism of Action 
Latest Stage of DevelopmentPhase I
IndicationAmyotrophic lateral sclerosis (ALS)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today